- Home
- BOE vs TLRY Comparison
BOE vs TLRY Comparison
Compare BOE & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOE
- TLRY
- Stock Information
- Founded
- BOE 2005
- TLRY N/A
- Country
- BOE United States
- TLRY Canada
- Employees
- BOE N/A
- TLRY N/A
- Industry
- BOE Trusts Except Educational Religious and Charitable
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- BOE Finance
- TLRY Health Care
- Exchange
- BOE Nasdaq
- TLRY Nasdaq
- Market Cap
- BOE 658.1M
- TLRY 624.7M
- IPO Year
- BOE N/A
- TLRY 2018
- Fundamental
- Price
- BOE $11.63
- TLRY $1.18
- Analyst Decision
- BOE
- TLRY Buy
- Analyst Count
- BOE 0
- TLRY 4
- Target Price
- BOE N/A
- TLRY $1.58
- AVG Volume (30 Days)
- BOE 166.1K
- TLRY 60.2M
- Earning Date
- BOE 01-01-0001
- TLRY 10-09-2025
- Dividend Yield
- BOE 7.30%
- TLRY N/A
- EPS Growth
- BOE N/A
- TLRY N/A
- EPS
- BOE N/A
- TLRY N/A
- Revenue
- BOE N/A
- TLRY $821,309,000.00
- Revenue This Year
- BOE N/A
- TLRY $6.66
- Revenue Next Year
- BOE N/A
- TLRY $4.75
- P/E Ratio
- BOE N/A
- TLRY N/A
- Revenue Growth
- BOE N/A
- TLRY 4.10
- 52 Week Low
- BOE $8.80
- TLRY $0.35
- 52 Week High
- BOE $10.48
- TLRY $1.88
- Technical
- Relative Strength Index (RSI)
- BOE 57.80
- TLRY 55.25
- Support Level
- BOE $11.46
- TLRY $1.03
- Resistance Level
- BOE $11.77
- TLRY $1.22
- Average True Range (ATR)
- BOE 0.08
- TLRY 0.10
- MACD
- BOE 0.01
- TLRY -0.04
- Stochastic Oscillator
- BOE 58.48
- TLRY 28.85
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.